Physician profile
John Devin Watson
NPI 1386969137
$8,718.21
in general payments reported to CMS, 2019-2025
38 companies · $1,461 in 2025
The $1,461 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,401 · 2021: $544 · 2022: $382 · 2023: $181 · 2024: $3,750 · 2025: $1,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,773 · Travel and Lodging: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,772.68 |
| Travel and Lodging | $618.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,008.41 | 2019-2025 | Gore Acuseal Vascular Graft, Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Vbx Balloon Expandable Endo |
| Medtronic, INC. | $1,720.40 | 2021-2025 | Endurant Iis, Hawkone, Heli-Fx Endoanchor System |
| Silk Road Medical, INC. | $1,209.14 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Inari Medical, INC. | $511.29 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $480.25 | 2021-2025 | Esprit, Perclose Proglide, Jeti |
| Philips North America LLC | $345.61 | 2019-2025 | (P84) Igt Devices Systems, Mechanical Tools, IV Other |
| Medtronic Vascular, INC. | $277.91 | 2019 | |
| Bolton Medical INC | $251.63 | 2019 | |
| Stryker Corporation | $220.88 | 2025 | Artix Mt, Flowtriever |
| Bard Peripheral Vascular, INC. | $202.32 | 2024-2025 | Rotarexs 6 F X 135 Cm, Lifestream, Lutonix Drug Coated Balloon |
| Boston Scientific Corporation | $163.99 | 2024 | Ekosonic |
| Ethicon US, LLC | $136.41 | 2025 | Surgiflo Hemostatic Matrix, Vistaseal |
| Cook Medical LLC | $125.73 | 2019-2025 | Zilver Ptx, Zenith |
| Organogenesis INC. | $108.44 | 2023 | Puraply |
| Astrazeneca Pharmaceuticals LP | $75.39 | 2021-2024 | Brilinta |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $75.04 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $70.46 | 2024-2025 | Verquvo |
| Bridgebio Pharma, INC. | $62.77 | 2025 | Attruby |
| Merit Medical Systems INC | $60.99 | 2021 | |
| Amgen INC. | $57.48 | 2024-2025 | Repatha, Repatha |
| Endologix LLC | $50.00 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $45.91 | 2024 | Arcalyst |
| Novo Nordisk INC | $44.92 | 2024 | Wegovy |
| Terumo Medical Corporation | $43.84 | 2021-2025 | Optitorque, Metacross Otw, Glidewire |
| Lemaitre Vascular, INC. | $43.25 | 2019 | |
| Atricure, INC. | $40.30 | 2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Epi-Sense Guided Coagulation System With Visitrax |
| Abiomed | $37.73 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.52 | 2025 | Lifevest |
| Humacyte Global, INC. | $30.35 | 2025 | Symvess |
| Lifenet Health | $28.00 | 2025 | Theragenesis Wound Matrix |
| Advanced Oxygen Therapy INC. | $24.09 | 2021-2022 | |
| Baxter Healthcare | $21.64 | 2024 | Preveleak |
| Veryan Medical Incorporated | $21.52 | 2023 | Biomimics 3d Vascular Stent System |
| United Therapeutics Corporation | $20.65 | 2024 | Tyvaso |
| Acera Surgical, INC. | $19.96 | 2022 | |
| Convatec INC. | $15.80 | 2025 | |
| Eagle Pharmaceuticals, INC. | $15.77 | 2023 | |
| Scpharmaceuticals INC. | $14.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Devin Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.